首页 | 本学科首页   官方微博 | 高级检索  
文章检索
  按 检索   检索词:      
出版年份:   被引次数:   他引次数: 提示:输入*表示无穷大
  收费全文   13877篇
  免费   785篇
  国内免费   18篇
耳鼻咽喉   115篇
儿科学   445篇
妇产科学   268篇
基础医学   2821篇
口腔科学   145篇
临床医学   1353篇
内科学   2939篇
皮肤病学   368篇
神经病学   1114篇
特种医学   552篇
外科学   1738篇
综合类   34篇
现状与发展   1篇
一般理论   5篇
预防医学   721篇
眼科学   176篇
药学   928篇
中国医学   28篇
肿瘤学   929篇
  2023年   51篇
  2022年   44篇
  2021年   178篇
  2020年   127篇
  2019年   203篇
  2018年   375篇
  2017年   240篇
  2016年   283篇
  2015年   334篇
  2014年   373篇
  2013年   506篇
  2012年   999篇
  2011年   959篇
  2010年   469篇
  2009年   364篇
  2008年   830篇
  2007年   894篇
  2006年   824篇
  2005年   837篇
  2004年   779篇
  2003年   724篇
  2002年   656篇
  2001年   229篇
  2000年   187篇
  1999年   184篇
  1998年   54篇
  1997年   45篇
  1992年   78篇
  1991年   86篇
  1990年   96篇
  1989年   111篇
  1988年   86篇
  1987年   86篇
  1986年   80篇
  1985年   66篇
  1984年   60篇
  1979年   70篇
  1978年   48篇
  1974年   53篇
  1973年   46篇
  1936年   54篇
  1934年   43篇
  1933年   63篇
  1932年   66篇
  1931年   63篇
  1930年   52篇
  1929年   45篇
  1928年   52篇
  1927年   64篇
  1923年   41篇
排序方式: 共有10000条查询结果,搜索用时 15 毫秒
1.
2.
3.
Graefe's Archive for Clinical and Experimental Ophthalmology -  相似文献   
4.

Background

The ZOE-50 (NCT01165177) and ZOE-70 (NCT01165229) phase 3 clinical trials showed that the adjuvanted recombinant zoster vaccine (RZV) was ≥90% efficacious in preventing herpes zoster in adults. Here we present a comprehensive overview of the safety data from these studies.

Methods

Adults aged ≥50 (ZOE-50) and ≥70 (ZOE-70) years were randomly vaccinated with RZV or placebo. Safety analyses were performed on the pooled total vaccinated cohort, consisting of participants receiving at least one dose of RZV or placebo. Solicited and unsolicited adverse events (AEs) were collected for 7 and 30?days after each vaccination, respectively. Serious AEs (SAEs) were collected from the first vaccination until 12?months post-last dose. Fatal AEs, vaccination-related SAEs, and potential immune-mediated diseases (pIMDs) were collected during the entire study period.

Results

Safety was evaluated in 14,645 RZV and 14,660 placebo recipients. More RZV than placebo recipients reported unsolicited AEs (50.5% versus 32.0%); the difference was driven by transient injection site and solicited systemic reactions that were generally seen in the first week post-vaccination. The occurrence of overall SAEs (RZV: 10.1%; Placebo: 10.4%), fatal AEs (RZV: 4.3%; Placebo: 4.6%), and pIMDs (RZV: 1.2%; Placebo: 1.4%) was balanced between groups. The occurrence of possible exacerbations of pIMDs was rare and similar between groups. Overall, except for the expected local and systemic symptoms, the safety results were comparable between the RZV and Placebo groups irrespective of participant age, gender, or race.

Conclusions

No safety concerns arose, supporting the favorable benefit-risk profile of RZV.  相似文献   
5.
We evaluated RNA stability of Ebola virus in EDTA blood and urine samples collected from infected patients and stored in West Africa’s environmental conditions. In blood, RNA was stable for at least 18 days when initial cycle threshold values were <30, but in urine, RNA degradation occurred more quickly.  相似文献   
6.
Although hepatitis E virus (HEV) is the primary cause of enterically transmitted acute hepatitis and jaundice in developing countries, locally acquired HEV infections are increasing in nonendemic countries. As such, HEV is emerging as an underdiagnosed cause of infection. This report describes three clinically variable cases of HEV infection with unusual clinical presentations. These cases highlight the fact that HEV should be considered in the differential diagnosis of patients with unexplained hepatitis (acute or chronic) with or without extrahepatic manifestations. HEV should also be considered in patients with persistently elevated liver enzymes who have not travelled to known HEV-endemic regions. Lack of knowledge among physicians and an absence of standardized diagnostic tests may result in increased morbidity and mortality from HEV infection.  相似文献   
7.
8.
9.
10.
The actinobacterium strain ABH26 closely related to Saccharothrix xinjiangensis, isolated from an Algerian Saharan soil sample, exhibited highly antagonist activity against Gram-positive bacteria, yeasts and filamentous fungi. Its ability to produce antimicrobial compounds was investigated using several solid culture media. The highest antimicrobial activity was obtained on Bennett medium. The antibiotics secreted by strain ABH26 on Bennett medium were extracted by methanol and purified by reverse-phase HPLC using a C18 column. The chemical structures of the compounds were determined after spectroscopic (1H NMR, 13C NMR, 1H-1H COSY and 1H-13C HMBC spectra), and spectrometric (mass spectrum) analyses. Two new cyanogriside antibiotics named cyanogriside I (1) and cyanogriside J (2), were characterized along with three known caerulomycins, caerulomycin A (3), caerulomycin F (4) and caerulomycinonitrile (5). This is the first report of cyanogrisides and caerulomycins production by a member of the Saccharothrix genus. The minimum inhibitory concentrations (MIC) of these antibiotics were determined against pathogenic microorganisms.  相似文献   
设为首页 | 免责声明 | 关于勤云 | 加入收藏

Copyright©北京勤云科技发展有限公司  京ICP备09084417号